A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignancies

Pediatr Blood Cancer. 2015 Aug;62(8):1481-4. doi: 10.1002/pbc.25486. Epub 2015 Mar 18.

Abstract

Here we report on a child with Li-Fraumeni syndrome with a de novo TP53 mutation c.818G>A, who developed three malignancies at the age of 4 months, 4 and 5 years, respectively. We show that (i) in the choroid plexus carcinoma, the germline mutation was detected in a homozygous state due to copy-neutral LOH/uniparental disomy, (ii) in the secondary AML, a complex karyotype led to loss of the wild-type TP53 allele, (iii) in the Wilms tumor, the somatic mutation c.814G>A led to compound heterozygosity. The findings show that the complete inactivation of TP53 by different mechanisms is an important step towards tumorigenesis.

Keywords: Li-Fraumeni syndrome; TP53; choroid plexus carcinoma; leukemia; sarcoma; uniparental disomy (UPD).

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Carcinoma / genetics*
  • Cell Transformation, Neoplastic / genetics
  • Child
  • Choroid Plexus Neoplasms / genetics*
  • Female
  • Gene Silencing
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Li-Fraumeni Syndrome / genetics*
  • Li-Fraumeni Syndrome / therapy
  • Mutation
  • Sequence Analysis, DNA
  • Tumor Suppressor Protein p53 / genetics*
  • Wilms Tumor / genetics*

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53

Supplementary concepts

  • Choroid Plexus Carcinoma